These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11831698)

  • 1. Expression of the complementary-strand transcripts from BamHI-A region of the Epstein-Barr virus genome in various induced virus-carrying B cell lines.
    Zhang CX; Ooka T
    Virology; 1995 Apr; 208(1):180-8. PubMed ID: 11831698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.
    Fries KL; Sculley TB; Webster-Cyriaque J; Rajadurai P; Sadler RH; Raab-Traub N
    J Virol; 1997 Apr; 71(4):2765-71. PubMed ID: 9060630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES; Tomkinson B; Kieff E
    J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders.
    van Beek J; Brink AATP; Vervoort MBHJ; van Zijp MJM; Meijer CJLM; van den Brule AJC; Middeldorp JM
    J Gen Virol; 2003 Oct; 84(Pt 10):2647-2659. PubMed ID: 13679598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors.
    Smith PR; Gao Y; Karran L; Jones MD; Snudden D; Griffin BE
    J Virol; 1993 Jun; 67(6):3217-25. PubMed ID: 8098777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of Epstein-Barr virus BamHI-A rightward transcripts and their expression patterns in lytic and latent infections.
    Yamamoto T; Iwatsuki K
    J Med Microbiol; 2012 Oct; 61(Pt 10):1445-1453. PubMed ID: 22700548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analyses of the Epstein-Barr virus BamHI A transcripts.
    Sadler RH; Raab-Traub N
    J Virol; 1995 Feb; 69(2):1132-41. PubMed ID: 7815492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood.
    Chen H; Smith P; Ambinder RF; Hayward SD
    Blood; 1999 May; 93(9):3026-32. PubMed ID: 10216099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
    Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency.
    Brooks LA; Lear AL; Young LS; Rickinson AB
    J Virol; 1993 Jun; 67(6):3182-90. PubMed ID: 8388496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
    Schaefer BC; Strominger JL; Speck SH
    J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders.
    Brink AA; Meijer CJ; Nicholls JM; Middeldorp JM; van den Brule AJ
    Mol Pathol; 2001 Apr; 54(2):98-102. PubMed ID: 11322171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative RNA-Seq-based evaluation of Epstein-Barr virus transcription in type I latency Burkitt's lymphoma cells.
    Lin Z; Xu G; Deng N; Taylor C; Zhu D; Flemington EK
    J Virol; 2010 Dec; 84(24):13053-8. PubMed ID: 20943983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
    Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
    DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens.
    Mukohyama J; Iwakiri D; Zen Y; Mukohara T; Minami H; Kakeji Y; Shimono Y
    Oncotarget; 2016 Aug; 7(31):50150-50160. PubMed ID: 27367028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.